{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:28:09Z","timestamp":1768980489333,"version":"3.49.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N41A660176"],"award-info":[{"award-number":["N41A660176"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Cholangiocarcinoma (CCA) is a lethal cancer associated with chronic inflammation caused by\n                    <jats:italic>Opisthorchis viverrini<\/jats:italic>\n                    infection, with high prevalence in Thailand. Secretory leukocyte protease inhibitor (SLPI), a serine protease inhibitor involved in inflammation, has recently been identified as an oncogenic factor in several malignancies. However, its role in CCA remains unclear. Here, we demonstrate that SLPI is significantly upregulated during CCA development in both human and hamster-induced tissues. Higher SLPI expression was correlated with poor patient survival based on bioinformatic analyses. SLPI was elevated in highly metastatic CCA cell lines and further inducible by IL-6 stimulation. Overexpression of SLPI enhanced tumorigenic properties, including proliferation, migration, invasion, and in vivo tumor growth. SLPI also increased the activity of matrix metalloproteinases (MMP-2 and MMP-9), promoting metastatic potential. While conditioned media from SLPI-overexpressing cells did not affect angiogenesis, these cells promoted vasculogenic mimicry, with increased expression of VEGFA and VE-cadherin, and decreased N-cadherin. These findings suggest that SLPI promotes cholangiocarcinoma progression through inflammation-associated and vasculogenic mechanisms, highlighting its potential as a candidate molecular target for therapeutic intervention.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0340763","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T18:32:24Z","timestamp":1768933944000},"page":"e0340763","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Secretory leukocyte protease inhibitor (SLPI) promotes cholangiocarcinoma progression via inflammation-associated and vasculogenic mechanisms"],"prefix":"10.1371","volume":"21","author":[{"given":"Kangsadan","family":"Chueajedton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaiwat","family":"Chueaiphuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeranan","family":"Inpad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarawut","family":"Kumphune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Worasak","family":"Kaewkong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damratsamon","family":"Surangkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanlayanee","family":"Sawanyawisuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ubon","family":"Cha\u2019on","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1949-427X","authenticated-orcid":true,"given":"Suchada","family":"Phimsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"pone.0340763.ref001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/IJGM.S186854","article-title":"Cholangiocarcinoma: a guide for the nonspecialist","volume":"12","author":"M Alsaleh","year":"2018","journal-title":"Int J Gen Med"},{"issue":"1","key":"pone.0340763.ref002","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"T Liu","year":"2017","journal-title":"Sig Transduct Target Ther"},{"key":"pone.0340763.ref003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/149185","article-title":"Chronic Inflammation and Cytokines in the Tumor Microenvironment","volume":"2014","author":"G Landskron","year":"2014","journal-title":"Journal of Immunology Research"},{"issue":"9","key":"pone.0340763.ref004","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"JM Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"pone.0340763.ref005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MOG.0000000000000611","article-title":"Molecular classification of cholangiocarcinoma","volume":"36","author":"C Louis","year":"2020","journal-title":"Current Opinion in Gastroenterology"},{"issue":"6","key":"pone.0340763.ref006","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1165\/rcmb.2010-0095RT","article-title":"Secretory leukocyte protease inhibitor and elafin\/trappin-2: versatile mucosal antimicrobials and regulators of immunity","volume":"42","author":"J-M Sallenave","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"pone.0340763.ref007","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jobcr.2022.04.001","article-title":"The effect of secretory leukocyte protease inhibitor amnion membrane on incisional wound healing","volume":"12","author":"E Munadziroh","year":"2022","journal-title":"J Oral Biol Craniofac Res"},{"key":"pone.0340763.ref008","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cytogfr.2015.12.001","article-title":"Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response","volume":"28","author":"M Majchrzak-Gorecka","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"issue":"9","key":"pone.0340763.ref009","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jcp.48.9.876","article-title":"A \u201cquickscore\u201d method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas","volume":"48","author":"S Detre","year":"1995","journal-title":"J Clin Pathol"},{"issue":"1","key":"pone.0340763.ref010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ijc.25656","article-title":"Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis","volume":"129","author":"S Prakobwong","year":"2011","journal-title":"Int J Cancer"},{"issue":"12","key":"pone.0340763.ref011","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ijpara.2015.06.001","article-title":"Excretory\/secretory products of the carcinogenic liver fluke are endocytosed by human cholangiocytes and drive cell proliferation and IL6 production","volume":"45","author":"S Chaiyadet","year":"2015","journal-title":"Int J Parasitol"},{"issue":"1","key":"pone.0340763.ref012","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3892\/or.2016.5269","article-title":"Arctigenin, a lignan from Arctium lappa L., inhibits metastasis of human breast cancer cells through the downregulation of MMP-2\/-9 and heparanase in MDA-MB-231 cells","volume":"37","author":"C Lou","year":"2017","journal-title":"Oncol Rep"},{"issue":"9","key":"pone.0340763.ref013","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00011-017-1062-2","article-title":"Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines","volume":"66","author":"D Svensson","year":"2017","journal-title":"Inflamm Res"},{"issue":"5","key":"pone.0340763.ref014","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3748\/wjg.14.666","article-title":"Opisthorchis viverrini: the carcinogenic human liver fluke","volume":"14","author":"N Kaewpitoon","year":"2008","journal-title":"World J Gastroenterol"},{"key":"pone.0340763.ref015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12935-015-0182-4","article-title":"SLPI knockdown induced pancreatic ductal adenocarcinoma cells proliferation and invasion","volume":"15","author":"W Zhang","year":"2015","journal-title":"Cancer Cell Int"},{"issue":"3","key":"pone.0340763.ref016","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1349-7006.2009.01076.x","article-title":"Overexpression of protease inhibitor-dead secretory leukocyte protease inhibitor causes more aggressive ovarian cancer in vitro and in vivo","volume":"100","author":"N Devoogdt","year":"2009","journal-title":"Cancer Sci"},{"key":"pone.0340763.ref017","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cytogfr.2021.01.005","article-title":"Secretory Leukocyte Protease Inhibitor (SLPI) in mucosal tissues: Protects against inflammation, but promotes cancer","volume":"59","author":"S Nugteren","year":"2021","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"pone.0340763.ref018","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ygyno.2004.10.036","article-title":"Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis","volume":"96","author":"S Tsukishiro","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"10","key":"pone.0340763.ref019","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/mc.23445","article-title":"FAPhigh \u03b1-SMAlow cancer-associated fibroblast-derived SLPI protein encapsulated in extracellular vesicles promotes ovarian cancer development via activation of PI3K\/AKT and downstream signaling pathways","volume":"61","author":"L Sun","year":"2022","journal-title":"Mol Carcinog"},{"issue":"1","key":"pone.0340763.ref020","doi-asserted-by":"crossref","first-page":"2221978","DOI":"10.1080\/19490976.2023.2221978","article-title":"Dietary iron modulates gut microbiota and induces SLPI secretion to promote colorectal tumorigenesis","volume":"15","author":"C Liu","year":"2023","journal-title":"Gut Microbes"},{"issue":"1","key":"pone.0340763.ref021","doi-asserted-by":"crossref","first-page":"140","DOI":"10.7150\/ijbs.65676","article-title":"SLPI suppresses hepatocellular carcinoma progression via endoplasmic reticulum stress induced apoptosis","volume":"18","author":"J Sun","year":"2022","journal-title":"Int J Biol Sci"},{"issue":"2","key":"pone.0340763.ref022","article-title":"Secretory leukocyte protease inhibitor (SLPI) as a diagnostic biomarker and facilitator of cell proliferation in cholangiocarcinoma","volume":"5","author":"K Chueajedton","year":"2025","journal-title":"J Basic Appl Pharmacol"},{"issue":"7","key":"pone.0340763.ref023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006393","article-title":"Helminth infection\u2013induced malignancy","volume":"13","author":"PJ Brindley","year":"2017","journal-title":"PLoS Pathog"},{"issue":"2","key":"pone.0340763.ref024","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24550","article-title":"The secretory leukocyte protease inhibitor (SLPI) in pathophysiology of non-communicable diseases: Evidence from experimental studies to clinical applications","volume":"10","author":"P Mongkolpathumrat","year":"2024","journal-title":"Heliyon"},{"issue":"3","key":"pone.0340763.ref025","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/01.TP.0000110292.73873.25","article-title":"Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT","volume":"77","author":"M Maruyama","year":"2004","journal-title":"Transplantation"},{"issue":"33","key":"pone.0340763.ref026","doi-asserted-by":"crossref","first-page":"29999","DOI":"10.1074\/jbc.M203503200","article-title":"Secretory Leukocyte Protease Inhibitor Mediates Proliferation of Human Endometrial Epithelial Cells by Positive and Negative Regulation of Growth-associated Genes","volume":"277","author":"D Zhang","year":"2002","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"pone.0340763.ref027","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12935-023-03033-2","article-title":"Progranulin promoted the proliferation, metastasis, and suppressed apoptosis via JAK2-STAT3\/4 signaling pathway in papillary thyroid carcinoma","volume":"23","author":"Y Dong","year":"2023","journal-title":"Cancer Cell Int"},{"issue":"10","key":"pone.0340763.ref028","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/1878-0261.12552","article-title":"Progranulin sustains STAT3 hyper-activation and oncogenic function in colorectal cancer cells","volume":"13","author":"F Laudisi","year":"2019","journal-title":"Mol Oncol"},{"issue":"65","key":"pone.0340763.ref029","doi-asserted-by":"crossref","first-page":"108292","DOI":"10.18632\/oncotarget.22660","article-title":"Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers","volume":"8","author":"SV Kozin","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"pone.0340763.ref030","first-page":"527","article-title":"Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells","volume":"28","author":"B-D Choi","year":"2011","journal-title":"Int J Mol Med"},{"issue":"3","key":"pone.0340763.ref031","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ygyno.2011.04.052","article-title":"Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells","volume":"122","author":"E Hoskins","year":"2011","journal-title":"Gynecol Oncol"},{"key":"pone.0340763.ref032","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.canlet.2019.12.018","article-title":"Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p\/SLPI-mediated vasculogenic mimicry formation","volume":"473","author":"Z Yang","year":"2020","journal-title":"Cancer Letters"},{"issue":"7547","key":"pone.0340763.ref033","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nature14403","article-title":"A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis","volume":"520","author":"E Wagenblast","year":"2015","journal-title":"Nature"},{"key":"pone.0340763.ref034","article-title":"Blood supply, oxygenation status and metabolic micromilieu of breast cancers: characterization and therapeutic relevance","author":"P Vaupel","year":"2000","journal-title":"Int J Oncol"},{"issue":"3","key":"pone.0340763.ref035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/ijtm1030012","article-title":"The Metastatic Capacity of Melanoma Reveals Alternative Pathways of Cancer Dissemination","volume":"1","author":"M Corsini","year":"2021","journal-title":"IJTM"},{"issue":"11","key":"pone.0340763.ref036","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3390\/biom9110678","article-title":"Endothelial-Cell-Derived Human Secretory Leukocyte Protease Inhibitor (SLPI) Protects Cardiomyocytes against Ischemia\/Reperfusion Injury","volume":"9","author":"K Kongpol","year":"2019","journal-title":"Biomolecules"},{"issue":"2","key":"pone.0340763.ref037","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.2156","article-title":"The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway","volume":"212","author":"T Sugino","year":"2007","journal-title":"J Pathol"},{"issue":"7","key":"pone.0340763.ref038","first-page":"1495","article-title":"SLPI promotes the gastric cancer growth and metastasis by regulating the expression of P53, Bcl-2 and Caspase-8","volume":"21","author":"X-Y Du","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"36","key":"pone.0340763.ref039","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1038\/onc.2016.13","article-title":"Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer","volume":"35","author":"D Zheng","year":"2016","journal-title":"Oncogene"},{"issue":"4","key":"pone.0340763.ref040","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12094-014-1232-4","article-title":"Secretory leukocyte protease inhibitor is a proliferation and survival factor for pancreatic cancer cells","volume":"17","author":"J Zuo","year":"2015","journal-title":"Clin Transl Oncol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0340763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T18:32:31Z","timestamp":1768933951000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0340763"}},"subtitle":[],"editor":[{"given":"Zu","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0340763","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]}}}